X hits on this document

23 views

0 shares

0 downloads

0 comments

6 / 7

Y. WANG et al.

  • 2.

    Leung PW, Luk SL, Ho TP, Taylor E, Mak FL, Bacon-Shone J. 1996. The diagnosis and prevalence of hyperactivity in Chinese schoolboys. Br. J. Psychiatry 168: 486-496.

  • 3.

    Brown RT, Freeman WS, Perrin JM, Stein MT, Amler RW, Feldman HM, Pierce K, Wolraich ML. 2001. Prevalence and assessment of attention-deficit/hyperactivity disorder in primary care settings. Pediatrics. 107: E43.

  • 4.

    Heiser P, Friedel S, Dempfle A, Konrad K, Smidt J, Grabarkiewicz J, Herpertz-Dahlmann B, Remschmidt H, Hebebrand J. 2004. Molecular genetic aspects of attention-deficit/hyperactivity disorder. Neurosci. Biobehav. Rev. 28: 625-641.

  • 5.

    Joseph J. 2002. Adoption study of ADHD. J. Am. Acad. Child Adolesc. Psychiatry. 41: 1389-1390.

  • 6.

    Thapar A, Holmes J, Poulton K, Harrington R. 1999. Genetic basis of attention deficit and hyperactivity. Br. J. Psychiatry. 174: 105-111.

  • 7.

    Tucha O, Prell S, Mecklinger L, Bormann-Kischkel C, Kubber S, Linder M, Walitza S, Lange KW. 2006. Effects of methylphenidate on multiple components of attention in children with attention deficit hyperactivity disorder. Psychopharmacology (Berl). 185: 315-326.

  • 8.

    Ramos-Quiroga JA, Bosch-Munso R, Castells-Cervello X, Nogueira-Morais M, Garcia-Gimenez E, Casasnd therapeutic-Brugue M. 2006. Attention deficit hyperactivity disorder in adults: a clinical a characterisation. Rev. Neurol. 42: 600-606.

  • 9.

    Biederman J, Faraone SV. 2005. Attention-deficit hyperactivity disorder. Lancet. 366: 237-248.

  • 10.

    Seeman P, Madras BK. 1998. Anti-hyperactivity medication: methylphenidate and amphetamine. Mol. Psychiatry 3: 386-396.

  • 11.

    Waldman ID, Gizer IR. 2006. The genetics of attention deficit hyperactivity disorder. Clin. Psychol. Rev. 6: 396-432.

  • 12.

    Trinh JV, Nehrenberg DL, Jacobsen JP, Caron MG, Wetsel WC. 2003. Differential psychostimulant-induced activation of neural circuits in dopamine transporter knockout and wild type mice. Neuroscience. 118: 297-310.

  • 13.

    Giros B, Jaber M, Jones SR, Wightman RM, Caron MG. 1996. Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature. 379: 606-612.

  • 14.

    Jiang S, Xin R, Wu X, Lin S, Qian Y, Ren D, Tang G, Wang D. 2000. Association between attention deficit hyperactivity disorder and the DXS7 locus. Am. J. Med. Genet. 96: 289-292.

  • 15.

    Cook EH, Stein MA, Krasowski MD, Cox NJ, Olkon DM, Kieffer JE, Leventhal BL. 1995. Association of attention deficit disorder and the dopamine transporter gene. Am. J. Hum. Genet. 56: 993-998.

  • 16.

    Kim YS, Leventhal BL, Kim SJ, Kim BN, Cheon KA, Yoo HJ, Kim SJ, Badner J, Cook EH. 2005. Family-based association study of DAT1 and DRD4 polymorphism in Korean children with ADHD. Neurosci. Lett. 390: 176-181.

  • 17.

    Langley K, Turic D, Peirce TR, Mills S, Van Den Bree MB, Owen MJ, O'Donovan, MC, Thapar A. 2005. No support for association between the dopamine transporter (DAT1) gene and ADHD. Am. J. Med. Genet. B Neuropsychiatr. Genet. 139: 7-10.

  • 18.

    Lim MH, Kim HW, Paik KC, Cho SC, Yoon do Y, Lee HJ. 2006. Association of the DAT1 polymorphism with attention deficit hyperactivity disorder (ADHD): a family-based approach. Am. J. Med. Genet. B Neuropsychiatr. Genet. 141: 309-311.

332

Document info
Document views23
Page views23
Page last viewedThu Dec 08 12:43:15 UTC 2016
Pages7
Paragraphs203
Words3617

Comments